Cryo-Cell International, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Description of Business and Summary of Significant Accounting Policies (Tables)

Description of Business and Summary of Significant Accounting Policies (Tables)

12 Months Ended

Nov. 30, 2016

Estimated Useful Lives of Property and Equipment

Estimated useful lives of property and equipment are as follows:


Furniture and equipment		3-10 years
Leasehold improvements		Lesser of 8-10 years or the lives of the leases
Computer software – internal use		1-5 years

Financial Assets and Liabilities Measured at Fair Value on Recurring Basis

The following table summarizes our financial assets and liabilities measured at fair value on a recurring basis as of November 30, 2016 and 2015, respectively, segregated among the appropriate levels within the fair value hierarchy:


	Fair Value at		Fair Value Measurements
	November 30,		at November 30, 2016 Using
Description	2016		Level 1		Level 2		Level 3
Assets:
Trading securities	$	304,142	$	304,142		—		—
Available-for-sale securities		320,081		320,081		—		—

Total	$	624,223	$	624,223		—		—


	Fair Value at		Fair Value Measurements
	November 30,		at November 30, 2015 Using
Description	2015		Level 1		Level 2		Level 3
Assets:
Trading securities	$	136,798	$	136,798		—		—
Available-for-sale securities		473,626		473,626		—		—

Total	$	610,424	$	610,424		—		—

Calculation of Basic and Diluted Net (Loss) Income per Common Share

The composition of basic and diluted net (loss) income per share is as follows:


	November 30, 2016			November 30, 2015
Numerator:
Net (Loss) Income	($	1,320,800	)	$	8,106,343
Denominator:
Weighted-average shares outstanding-basic		8,112,791			9,537,607
Dilutive common shares issuable upon exercise of stock options		—			257,972

Weighted-average shares-diluted		8,112,791			9,795,579

(Loss) Income per share:
Basic	($	0.16	)	$	0.85

Diluted	($	0.16	)	$	0.83